OrthoPediatrics Corp. (NASDAQ:KIDS) Receives $24.00 Average PT from Analysts

by · The Markets Daily

OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $24.00.

Several equities analysts recently issued reports on KIDS shares. Truist Financial set a $18.00 target price on shares of OrthoPediatrics in a report on Friday, October 10th. Wall Street Zen downgraded OrthoPediatrics from a “hold” rating to a “sell” rating in a research note on Saturday. Needham & Company LLC cut their target price on OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating on the stock in a research report on Wednesday, October 29th. BTIG Research reiterated a “buy” rating and issued a $23.00 target price on shares of OrthoPediatrics in a report on Wednesday, October 29th. Finally, Lake Street Capital dropped their price target on OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, October 10th.

Read Our Latest Stock Analysis on KIDS

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Prosight Management LP boosted its position in shares of OrthoPediatrics by 319.2% during the 3rd quarter. Prosight Management LP now owns 308,707 shares of the company’s stock worth $5,720,000 after purchasing an additional 235,060 shares in the last quarter. Millennium Management LLC boosted its holdings in OrthoPediatrics by 55.3% in the first quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock worth $16,172,000 after acquiring an additional 233,873 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in OrthoPediatrics by 116.5% in the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company’s stock worth $7,173,000 after acquiring an additional 179,733 shares in the last quarter. Deerfield Management Company L.P. grew its stake in OrthoPediatrics by 1,153.4% in the third quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock valued at $3,597,000 after acquiring an additional 178,623 shares during the period. Finally, Paradigm Capital Management Inc. NY increased its holdings in shares of OrthoPediatrics by 1,607.0% during the first quarter. Paradigm Capital Management Inc. NY now owns 170,700 shares of the company’s stock valued at $4,204,000 after acquiring an additional 160,700 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Trading Down 0.5%

Shares of KIDS stock opened at $17.28 on Friday. OrthoPediatrics has a 1-year low of $15.28 and a 1-year high of $27.60. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. The stock has a market cap of $433.38 million, a price-to-earnings ratio of -8.86 and a beta of 1.06. The stock has a 50-day moving average of $17.44 and a 200-day moving average of $19.38.

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last announced its earnings results on Monday, January 9th. The company reported ($0.15) EPS for the quarter. OrthoPediatrics had a negative net margin of 20.06% and a negative return on equity of 6.86%. The company had revenue of $25.08 million during the quarter. On average, equities research analysts forecast that OrthoPediatrics will post -0.93 earnings per share for the current year.

OrthoPediatrics Company Profile

(Get Free Report)

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

Read More